AffiliationDepartment of Clinical Oncology, The Christie NHS Foundation Trust, 550 Wilmslow Road, Manchester, M20 4BX, United Kingdom.
MetadataShow full item record
AbstractMortality from lung cancer is increasing in patients>/=70 years. Radiotherapy has an important role in the treatment of lung cancer for this group. Despite this, there have been few elderly specific trials of radiotherapy in lung cancer and current treatment is often based on evidence extrapolated from studies treating younger patients. This review of the literature examines the impact of radiotherapy for the radical and palliative treatment of non-small-cell and small-cell lung cancer, on survival, treatment-related toxicity and quality of life in the elderly. We also comment on the need for validated, practical geriatric screening and assessment tools to help predict toxicity to treatment.
CitationRadiotherapy for lung cancer in the elderly. 2010: Lung Cancer
- Do elderly people with lung cancer benefit from palliative radiotherapy?
- Authors: Turner NJ, Muers MF, Haward RA, Mulley GP
- Issue date: 2005 Aug
- Radiochemotherapy in the elderly with lung cancer.
- Authors: Casas F, Kepka L, Agarwal JP, Dawotola D, Gaye P, Abdel-Wahab S, Vashkevitch L, Saghatelyan T, Perin B, Jeremic B
- Issue date: 2009 Oct
- The role of radiotherapy in lung cancer: where is the evidence?
- Authors: Jassem J
- Issue date: 2007 May
- Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
- Authors: van den Hout WB, Kramer GW, Noordijk EM, Leer JW
- Issue date: 2006 Dec 20
- Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
- Authors: Sundstrøm S, Bremnes R, Aasebø U, Aamdal S, Hatlevoll R, Brunsvig P, Johannessen DC, Klepp O, Fayers PM, Kaasa S
- Issue date: 2004 Mar 1